VoCHI - Cost-effectiveness analysis of Vaccination to Prevent COVID-19

Project start date: June 2020 - Present

Background: 
Since the pandemic began in March 2020, the US has experienced over 75 million cases of COVID-19, with significant morbidity and mortality. Vaccination rates in the US lag behind those of other peer countries and pediatric vaccination rates lag behind those of adults.

Objectives:
To project costs and health outcomes for available vaccine products and evaluate the cost-effectiveness of vaccination against COVID-19 illness for different age and risk groups, assuming various levels of concomitant risk mitigation strategies.

Research Topics & Methods:

• Cost-effectiveness analysis
• Simulation modeling

Implications:
Immunizations are among the most effective health interventions available in the US. The Centers for Disease Control and Prevention (CDC) relies on economic studies of immunization programs to guide immunization policies and practice.

Funding statement:
The project is funded by the Susan B. Meister Child Health Evaluation and Research Center and the Valuation of Child Health Initiative (VoCHI)

Collaborators:
Lisa Prosser, PhD
Marilyn Fisher Blanch Research Professor of Pediatrics, University of Michigan

David Hutton, PhD
Associate Professor, School of Public Health, University of Michigan

Emily Martin, PhD
Associate Professor, School of Public Health, University of Michigan

Marisa Eisenberg, PhD
Associate Professor, School of Public Health, University of Michigan

Acham Gebremariam, MS
Decision Modeler, University of Michigan

Graduate Students:
Grace Chung, MPH
Janamarie Perroud, BS
Anton Avancena, MPH
Tran Doan, PhD
David Suh, MPH
Chris Cadham, MPH
Ellen Kim Deluca, MPH
Huey-Fen Chen, PhD